Literature DB >> 19702070

Levofloxacin-induced severe thrombocytopenia.

Chantana Polprasert1, Kannadit Prayongratana.   

Abstract

BACKGROUND: Thrombocytopenia following drug administration is commonly found in clinical practice. Recognition of this condition is important for further management of the patients. Many drugs were reported to be the cause of drug induced thrombocytopenia but levofloxacin was rarely reported. CASE REPORT: We present a seventy-eight-year-old male patient who developed severe thrombocytopenia with hemoptysis after taking levofloxacin for 4 days due to infected bronchiectasis. His platelet count was gradually recovered to normal value after the discontinuation of levofloxacin.
CONCLUSION: Levofloxacin can cause severe thrombocytopenia. Specific antibody to platelet surface glycoproteins caused by levofloxacin should be further studied to confirm the association.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702070

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  Drug-induced immune thrombocytopenia due to moxifloxacin.

Authors:  Timothy J Coker
Journal:  BMJ Case Rep       Date:  2013-01-17

2.  Antimicrobial-Induced Cytopenia and Bone Marrow Hypocellularity in Patients with Cirrhosis.

Authors:  Anupama Patil; Vikas Khillan; Monika Thakur; Pratibha Kale; Chhagan Bihari
Journal:  Bone Marrow Res       Date:  2018-05-14

3.  Severe Thrombocytopenia in a Patient with COVID-19.

Authors:  Eliel Nham; Jae Hoon Ko; Byeong Ho Jeong; Kyungmin Huh; Sun Young Cho; Cheol In Kang; Doo Ryeon Chung; Kyong Ran Peck
Journal:  Infect Chemother       Date:  2020-07-13

4.  A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.

Authors:  Ameen M Mohammad; Azri S H Sgery; Nawfal R Hussein
Journal:  Ann Med Surg (Lond)       Date:  2021-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.